Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022)

Senti Biosciences Holdings (SNTI) posted quarterly Current Taxes of $50044.0 for Q1 2022, down 69.46% quarter-over-quarter from $163839.0 in Q4 2021.

Senti Biosciences Holdings (SNTI) Current Taxes (2021 - 2022) Analysis & Trends

Senti Biosciences Holdings' Current Taxes history runs 2 years deep, the most recent figure standing at $50044.0 for Q1 2022.

In Q1 2022, Current Taxes changed N/A year-over-year to $50044.0; the TTM figure through Mar 2022 stood at $50044.0 (changed N/A YoY), while the FY2021 annual figure was $163839.0, changed N/A from the prior year.
Current Taxes for Q1 2022 stood at $50044.0, down from $163839.0 in the prior quarter.
The five-year high for Current Taxes was $163839.0 in Q4 2021, with the low at $50044.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.04 Bn	130.19 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.58 Bn	77.59 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.34 Bn	1.37 Bn	49.00 Mn
4	Moderna	56.52 Bn	51.38 Bn	52.00 Mn	-
5	BeOne Medicines	42.04 Bn	36.94 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.67 Bn	27.36 Bn	992.69 Mn	-
7	Insmed	27.27 Bn	26.11 Bn	358.27 Mn	-
8	BioNTech SE	27.14 Bn	8.75 Bn	668.28 Mn	76.36 Mn
9	Royalty Pharma	27.12 Bn	26.28 Bn	-	-
10	Senti Biosciences Holdings	13.24 Mn	13.24 Mn	-	-

Download Data